PMID- 28761985 OWN - NLM STAT- MEDLINE DCOM- 20171212 LR - 20181113 IS - 1432-2307 (Electronic) IS - 0945-6317 (Linking) VI - 471 IP - 6 DP - 2017 Dec TI - Synovial sarcoma showing loss of a green signal in SS18 fluorescence in situ hybridization: a clinicopathological and molecular study of 12 cases. PG - 799-807 LID - 10.1007/s00428-017-2211-2 [doi] AB - The phenomenon of losing a green signal in synovial sarcoma (SS) using the SS18 break-apart probe by fluorescence in situ hybridization (FISH) has been poorly described. In this study, 12 SS with missing a green signal were identified. This series included 7 males and 5 females, aged 17 to 69 years (median, 38.5 years). The tumors involved the extremities (50%), mediastinum (16.7%), hypopharynx (8.3%), neck (8.3%), thyroid (8.3%), and retroperitoneum (8.3%). The tumors were classified as monophasic SS (58.3%) and poorly differentiated SS (41.7%). An anaplastic SS showing features of pleomorphic sarcoma was observed. Immunostaining for TLE1, BCL2, CD99, epithelial membrane antigen, cytokeratin (AE1/AE3), cytokeratin 7, S-100 protein, and CD34 was consistent with typical SS. In FISH, all the tumors showed the pattern of 1 to 3 fused signal(s) with 1 to 3 red signal(s), without corresponding a green signal. The fusion transcripts included SS18-SSX1 (8/10, 80%) and SS18-SSX2 (2/10, 20%) fusions. Median and 5-year overall survival were 19.1 months and 43.6%, respectively. In conclusion, we reported a series of SS losing a green signal in the SS18 FISH assay. We propose that this variant FISH pattern should be interpreted as a peculiar unbalanced rearrangement of the SS18 gene and subsequent SS18-SSX fusion test should be recommended. The cases in this study seem to show some unusual clinicopathological features, including unusual locations, higher proportions of poorly differentiated SS, and aggressive clinical course. However, whether this variant FISH pattern is associated with peculiar clinicopathologic features awaits larger series. FAU - Jiang, Dan AU - Jiang D AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, 610041, China. FAU - Peng, Ran AU - Peng R AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, 610041, China. FAU - Yan, Xiaochu AU - Yan X AD - Institute of Pathology and Southwest Cancer Center, Southwest Hospital and Key Laboratory of Tumor Immunopathology of the Ministry of Education of China, Third Military Medical University, Chongqing, 400038, China. FAU - Chen, Min AU - Chen M AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, 610041, China. FAU - Lan, Ting AU - Lan T AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, 610041, China. FAU - Chen, Huijiao AU - Chen H AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, 610041, China. FAU - Zhang, Zhang AU - Zhang Z AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, 610041, China. FAU - Jing, Wenyi AU - Jing W AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, 610041, China. FAU - Jiang, Lili AU - Jiang L AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, 610041, China. FAU - Ma, Limei AU - Ma L AD - Department of Pathology, The Third People's Hospital of Zigong City, Zigong, 643020, China. FAU - Zhang, Hongying AU - Zhang H AD - Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, 610041, China. hy_zhang@scu.edu.cn. LA - eng GR - 81472510/National Natural Science Foundation of China/ GR - 81272944/National Natural Science Foundation of China/ GR - 81401990/National Natural Science Foundation of China/ PT - Journal Article DEP - 20170731 PL - Germany TA - Virchows Arch JT - Virchows Archiv : an international journal of pathology JID - 9423843 RN - 0 (Biomarkers, Tumor) RN - 0 (Oncogene Proteins, Fusion) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Repressor Proteins) RN - 0 (SS18 protein, human) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Biomarkers, Tumor/*genetics MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Male MH - Middle Aged MH - Oncogene Proteins, Fusion/genetics MH - Proto-Oncogene Proteins/*genetics MH - Repressor Proteins/*genetics MH - Sarcoma, Synovial/*genetics/pathology MH - Young Adult OTO - NOTNLM OT - Fluorescence in situ hybridization OT - Loss of a green signal OT - Pleomorphism OT - SS18 OT - Synovial sarcoma EDAT- 2017/08/02 06:00 MHDA- 2017/12/13 06:00 CRDT- 2017/08/02 06:00 PHST- 2017/05/20 00:00 [received] PHST- 2017/07/24 00:00 [accepted] PHST- 2017/07/09 00:00 [revised] PHST- 2017/08/02 06:00 [pubmed] PHST- 2017/12/13 06:00 [medline] PHST- 2017/08/02 06:00 [entrez] AID - 10.1007/s00428-017-2211-2 [pii] AID - 10.1007/s00428-017-2211-2 [doi] PST - ppublish SO - Virchows Arch. 2017 Dec;471(6):799-807. doi: 10.1007/s00428-017-2211-2. Epub 2017 Jul 31.